Patients with head and neck cancer cured by radiation therapy: A survey of the dry mouth syndrome in long‐term survivors
Top Cited Papers
- 23 July 2002
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 24 (8) , 737-747
- https://doi.org/10.1002/hed.10129
Abstract
Background: Xerostomia can have a significant impact on the quality of life of patients treated by radiation therapy (RT) for cancer in the head and neck. The first aim of the study was to evaluate the degree of xerostomia in 39 long‐term survivors treated between 1965–1995 by conventional two‐dimensional radiation therapy and currently without evidence of disease. The second aim was to develop a concise instrument to evaluate the subjective aspects of xerostomia.Methods: A newly developed questionnaire and a visual analog scale (VAS) were used in analyzing the degree of dry mouth and xerostomia‐related problems. The radiation dose received by the major salivary glands was estimated by analyzing two‐dimensional simulation films.Results: Sixty‐four percent of the patients experienced a moderate to severe degree of xerostomia. In the multivariate analysis, three questions regarding dry mouth, eating, and speech were particularly discriminatory for establishing the degree of xerostomia as expressed by the VAS score.Conclusions: In this survey, 64% of the long‐term survivors, after treatment by conventional two‐dimensional radiation therapy for a malignancy in the head and neck region, still experienced a moderate to severe degree of permanent xerostomia. A simplified instrument to evaluate xerostomia subjectively can consist of the VAS score and three graded questions. © 2002 Wiley Periodicals, Inc. Head Neck 24: 737–747, 2002Keywords
This publication has 75 references indexed in Scilit:
- Parotid Sparing Study in Head and Neck Cancer Patients Receiving Bilateral Radiation Therapy: One-year ResultsJournal of Dental Research, 1997
- Influence of Late Side-Effects Upon Daily Life After Radiotherapy for Laryngeal and Pharyngeal CancerActa Oncologica, 1994
- Parotid gland function during and following radiotherapy of malignancies in the head and neckEuropean Journal Of Cancer, 1992
- A clinical comparative trial of saliva substitutes in radiation‐induced salivary gland hypofunctionSpecial Care in Dentistry, 1992
- Assessing quality of life in patients treated for advanced head and neck cancerClinical Oncology, 1991
- Evaluation of Submandibular Salivary Flow Rate in Different Age GroupsJournal of Dental Research, 1988
- Effect of the application of a mucin‐based saliva substitute on the oral microflora of xerostomic patientsJournal of Oral Pathology & Medicine, 1987
- A double-blind crossover trial of CMC- and mucin-containing saliva substitutesInternational Journal of Oral & Maxillofacial Surgery, 1986
- Alterations in whole saliva flow rate induced by fractionated radiotherapyAmerican Journal of Roentgenology, 1978